Supreme Court Should Hear Appeal In Lawsuit To Expand Access To Experimental Rx For Terminally Ill Patients, Op-Ed States

Main Category: Cancer / Oncology
Also Included In: Public Health;  Litigation / Medical Malpractice
Article Date: 14 Jan 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The U.S. Supreme Court on Friday will consider a request to hear an appeal in a lawsuit against FDA that seeks access to experimental medications for terminally ill cancer patients, a case that has raised "profound issues regarding the right of individuals to make their own health care decisions," Steven Walker, co-founder of the Abigail Alliance for Better Access to Developmental Drugs, writes in a Wall Street Journal opinion piece.

Terminally ill patients "search for clinical trials of new drugs that might extend their lives," but most do not qualify or "learn the trial is fully enrolled and closed, or too far away," Walker writes. In addition, some terminally ill patients who enroll in trials "face a 50-50 chance of getting a placebo," he writes, adding, "Many are allowed to die without being told about or offered the active drugs."

FDA "commonly insists on statistically comparing the timing and severity of the deaths of untreated (placebo) patients with those of patients who receive the potentially effective drug," a practice that "renders the FDA's vaunted 'science' for drugs intended to treat terminal illnesses little more than a crude measurement of the height and accrual rate of two piles of bodies," according to Walker. He adds, "No terminal patient has the time needed to wrestle with the FDA in court if they first have to establish a right to do so."

Walker writes, "FDA and a majority of the D.C. Circuit Court of Appeals think terminally ill Americans are excluded from the fundamental right to pursue life," concluding, "The Supreme Court now has the opportunity to ... correct those egregious judgments" (Walker, Wall Street Journal, 1/11).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Supreme Court Should Hear Appeal In Lawsuit To Expand Access To Experimental Rx For Terminally Ill Patients, Op-Ed States." Medical News Today. MediLexicon, Intl., 14 Jan. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/93826.php>

APA
Kaiser. (2008, January 14). "Supreme Court Should Hear Appeal In Lawsuit To Expand Access To Experimental Rx For Terminally Ill Patients, Op-Ed States." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/93826.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »